Walgreens Boots Alliance (WBA) Stock Forecast, Price & News

12 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Walgreens Boots Alliance in the last year. There are currently 1 sell rating, 8 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" WBA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in WBA, but not buy additional shares or sell existing shares.
View WBA analyst ratings or view top-rated stocks.

12 analysts have issued 12 month price targets for Walgreens Boots Alliance's shares. Their WBA share price forecasts range from $27.00 to $54.00. On average, they anticipate the company's share price to reach $35.69 in the next year. This suggests a possible upside of 69.0% from the stock's current price.
View analysts price targets for WBA or view top-rated stocks among Wall Street analysts.

Walgreens Boots Alliance's stock was trading at $37.36 at the beginning of 2023. Since then, WBA shares have decreased by 43.5% and is now trading at $21.12.
View the best growth stocks for 2023 here.

Walgreens Boots Alliance saw a increase in short interest in August. As of August 31st, there was short interest totaling 42,910,000 shares, an increase of 20.5% from the August 15th total of 35,620,000 shares. Based on an average daily volume of 10,680,000 shares, the short-interest ratio is presently 4.0 days. Approximately 6.0% of the shares of the stock are sold short.
View Walgreens Boots Alliance's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, October 12th 2023.
View our WBA earnings forecast.

Walgreens Boots Alliance will be holding an earnings conference call on Thursday, October 12th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 647-362-9199 with passcode "8277955".

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) posted its quarterly earnings data on Tuesday, June, 27th. The pharmacy operator reported $1.00 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.07 by $0.07. The pharmacy operator earned $35.42 billion during the quarter, compared to analyst estimates of $34.32 billion. Walgreens Boots Alliance had a negative net margin of 2.44% and a positive trailing twelve-month return on equity of 12.62%. The business's revenue for the quarter was up 8.6% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.96 earnings per share.
Read the conference call transcript.

Walgreens Boots Alliance declared a quarterly dividend on Wednesday, July 12th. Investors of record on Monday, August 21st will be given a dividend of $0.48 per share on Tuesday, September 12th. This represents a $1.92 annualized dividend and a yield of 9.09%. The ex-dividend date is Friday, August 18th.
Read our dividend analysis for WBA.

ETFs with the largest weight of Walgreens Boots Alliance (NASDAQ:WBA) stock in their portfolio include Invesco Dow Jones Industrial Average Dividend ETF (DJD), FT Cboe Vest DJIA Dogs 10 Target Income ETF (DOGG), Invesco S&P Ultra Dividend Revenue ETF (RDIV), Sound Equity Dividend Income ETF (DIVY), Sound Equity Income ETF (SDEI), First Trust Dow 30 Equal Weight ETF (EDOW), USCF Dividend Income Fund (UDI) and Invesco S&P 500 High Dividend Low Volatility ETF (SPHD).

Walgreens Boots Alliance (NASDAQ:WBA) pays an annual dividend of $1.92 per share and currently has a dividend yield of 9.09%. WBA has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
Read our dividend analysis for WBA.

Walgreens Boots Alliance issued an update on its FY 2023 earnings guidance on Friday, September, 1st. The company provided earnings per share guidance of $4.00-$4.00 for the period, compared to the consensus earnings per share estimate of $4.00. The company issued revenue guidance of -.

4,267 employees have rated Walgreens Boots Alliance Chief Executive Officer Stefano Pessina on Glassdoor.com. Stefano Pessina has an approval rating of 32% among the company's employees. This puts Stefano Pessina in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Walgreens Boots Alliance investors own include AT&T (T), Intel (INTC), CVS Health (CVS), Johnson & Johnson (JNJ), Walt Disney (DIS), Cisco Systems (CSCO), AbbVie (ABBV), Verizon Communications (VZ), Pfizer (PFE) and Exxon Mobil (XOM).

Walgreens Boots Alliance trades on the NASDAQ under the ticker symbol "WBA."

Walgreens Boots Alliance's stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (7.76%), State Street Corp (6.46%), Capital World Investors (2.27%), Geode Capital Management LLC (1.83%), Northern Trust Corp (0.90%) and Camber Capital Management LP (0.87%). Insiders that own company stock include John Patrick Driscoll, Kevin M Ban, Marco Patrick Anthony Pagni, Nancy M Schlichting, Rosalind G Brewer and Walgreens Boots Alliance, Inc.
View institutional ownership trends.

Shares of WBA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of WBA stock can currently be purchased for approximately $21.12.

Walgreens Boots Alliance (NASDAQ:WBA) has a market capitalization of $18.23 billion and generates $132.70 billion in revenue each year. The pharmacy operator earns $4.34 billion in net income (profit) each year or ($3.84) on an earnings per share basis.

The company employs 325,000 workers across the globe.

Walgreens Boots Alliance's mailing address is 108 Wilmot Road, Deerfield IL, 60015. The official website for the company is www.walgreensbootsalliance.com. The pharmacy operator can be reached via phone at (847) 315-3700, via email at investor.relations@wba.com, or via fax at 847-914-2804.